Management Strategies for Older Patients with Low-Risk Early-Stage Breast Cancer: A Physician Survey
When managing older patients with lower-risk hormone-receptor-positive (HR+), HER2 negative (HER2−) early-stage breast cancer (EBC), the harms and benefits of adjuvant therapies should be taken into consideration. A survey was conducted among Canadian oncologists on the definitions of “low risk” and...
Main Authors: | Mashari Alzahrani, Mark Clemons, Lynn Chang, Lisa Vendermeer, Angel Arnaout, Gail Larocque, Katherine Cole, Tina Hsu, Deanna Saunders, Marie-France Savard |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Current Oncology |
Subjects: | |
Online Access: | https://www.mdpi.com/1718-7729/29/1/1 |
Similar Items
-
Experiences and Perceptions of Older Adults with Lower-Risk Hormone Receptor-Positive Breast Cancer about Adjuvant Radiotherapy and Endocrine Therapy: A Patient Survey
by: Marie-France Savard, et al.
Published: (2021-12-01) -
Persistence to extended adjuvant endocrine therapy following Breast Cancer Index (BCI) testing in women with early-stage hormone receptor-positive (HR +) breast cancer
by: Julia Foldi, et al.
Published: (2023-06-01) -
Both “Vitamin L for Life” and “One Milligram of Satan”: A Multi-Perspective Qualitative Exploration of Adjuvant Endocrine Therapy Use after Breast Cancer
by: Kirsti I. Toivonen, et al.
Published: (2021-07-01) -
Prevalence and determinants of adherence to oral adjuvant endocrine therapy among breast cancer patients in Singapore
by: Eskinder Eshetu Ali, et al.
Published: (2017-01-01) -
Potentially Modifiable Factors Associated with Adherence to Adjuvant Endocrine Therapy among Breast Cancer Survivors: A Systematic Review
by: Kirsti I. Toivonen, et al.
Published: (2020-12-01)